Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Metagenomi, Inc. - Common Stock (NQ: MGX )

2.720 -0.180 (-6.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 60,026
Open 2.840
Bid (Size) 2.850 (1)
Ask (Size) 3.280 (1)
Prev. Close 2.900
Today's Range 2.720 - 2.945
52wk Range 2.630 - 12.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Peeling Back The Layers: Exploring Metagenomi Through Analyst Insights
Via Benzinga
Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
From Metagenomi, Inc.
Via GlobeNewswire

Performance

YTD
-73.62%
-73.62%
1 Month
-21.61%
-21.61%
3 Month
-57.76%
-57.76%
6 Month
-77.33%
-77.33%
1 Year
-73.62%
-73.62%

More News

Read More
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi to Participate in Upcoming Investor Conferences
From Metagenomi, Inc.
Via GlobeNewswire
Unveiling 4 Analyst Insights On Metagenomi
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Metagenomi, Target Hospitality, Helios, and LegalZoom and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Cogent Communications To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
MGX Stock Earnings: Metagenomi Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi, Inc. (MGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Dril-Quip, LPL Financial, Methode, and Metagenomi and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Metagenomi, Inc. (MGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
MGX Investors Have Opportunity to Join Metagenomi, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
METAGENOMI ALERT: Bragar Eagel & Squire, P.C. is Investigating Metagenomi, Inc. on Behalf of Metagenomi Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Metagenomi, Inc. (MGX)
From Kirby McInerney LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
From Law Offices of Frank R. Cruz
Via Business Wire
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
From Metagenomi, Inc.
Via GlobeNewswire
MGX Stock Earnings: Metagenomi Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
Via InvestorPlace
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
From Metagenomi, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.